Lyssavac-N

Lyssavac-N: A Reliable and Immunogenic Rabies Vaccine

Lyssavac-N is a purified duck embryo rabies vaccine designed to provide robust protection against rabies. While it is highly immunogenic when administered intramuscularly, it differs from other rabies vaccines in that it is a suspension with an added preservative, rather than a solution. When used according to the World Health Organization’s (WHO) intradermal regimen, Lyssavac-N may produce lower mean neutralizing antibody titers compared to other vaccines. However, increasing the volume of each dose from 0.1 mL to 0.2 mL can help achieve satisfactory titers.

Lyssavac-N is an effective option for post-exposure prophylaxis, particularly in scenarios where the standard intramuscular regimen is not feasible. Its unique formulation and the ability to adjust the dosage make it a versatile choice for various vaccination protocols. If you’re looking for a reliable and effective rabies vaccine, Lyssavac-N is a solid option to consider.